title: Nutrition in liver transplantation: too little or too much?
abstract: OBJECTIVE
  The purpose of this study was to review the most recent findings on approaches to managing the obesity and muscle wasting that are found in patients before and after liver transplantation.
  
  
  RESULTS
  A number of articles have contributed to the accumulating evidence that morbid obesity is not an absolute contraindication to liver transplantation with survival outcomes similar across BMI groups. Obesity is, however, a risk factor for early post-transplant complications and obesity-related comorbidities markedly increase this risk. Very limited data are as yet available, dietary, or otherwise, related to amelioration of these comorbidities and evidence that weight loss leads to improved outcomes in obese patients is lacking. Abdominal computed tomography imaging is increasingly being used to identify muscle wasting, and poorer post-transplant survival is seen in patients with significant muscle wasting. This modality has confirmed the persistence of depleted muscle stores after transplant extending well beyond 1 year. Coupled with this is a high incidence of weight gain and metabolic syndrome and the associated risks. Although dietary intervention and exercise are considered possible approaches to address these issues, work in these areas so far is sparse.
  
  
  CONCLUSIONS
  An urgent need exists for interventional studies on the basis of nutrition and/or exercise to address the challenges presented by both obesity and muscle wasting, which likely coexist in many patients in both the pretransplant and the post-transplant periods.
authors.affiliation: aDepartment of Surgery, University of Auckland bNutrition Services, Auckland City Hospital, Auckland, New Zealand.
authors.forename: Lindsay D
authors.initials: LD
authors.lastname: Plank
authors.forename: Kylie
authors.initials: K
authors.lastname: Russell
mesh_terms: D015992:Body Mass Index; D015897:Comorbidity; D004035:Diet Therapy; D005081:Exercise Therapy; D006801:Humans; D015994:Incidence; D016031:Liver Transplantation / Q000009:adverse effects* / Q000401:mortality; D024821:Metabolic Syndrome / Q000453:epidemiology / Q000209:etiology; D009752:Nutritional Status; D009765:Obesity / Q000150:complications* / Q000628:therapy; D012307:Risk Factors; D019282:Wasting Syndrome / Q000150:complications* / Q000628:therapy; D015430:Weight Gain